Xtrackers MSCI USA Health Care UCITS ETF 1c

ISIN IE000RNHIKK1 · XUHL EU

The Xtrackers MSCI USA Health Care UCITS ETF 1c is an exchange-traded index fund (ETF) from Xtrackers that tracks the MSCI USA Health Care index physically. Income is distributed to investors; it trades as a Europe-domiciled UCITS fund. The fund spreads across 57 individual holdings – the largest currently Eli Lilly at 16.40%. The full composition plus the sector and country breakdown are shown below; it is one of 104 ETFs we cover.

The ten largest holdings make up 60.9% of the fund, out of 57 in total. The largest sector is Health Care at 99.9% (as of Nov 2, 2026).

Alysly Data Analysis: XUHL

The 50 Largest Holdings

of 57 in total · as of Nov 2, 2026

Top holdings

#	Stock	Ticker	Weight
1	Eli Lilly	LLY	16.40%
2	Johnson & Johnson	JNJ	9.88%
3	AbbVie Inc.	ABBV	7.66%
4	UnitedHealth Group Incorporated	UNH	5.56%
5	Merck & Co. Inc.	MRK	5.39%
6	Thermo Fisher Scientific Inc.	TMO	3.93%
7	Amgen Inc.	AMGN	3.71%
8	Gilead Sciences Inc.	GILD	3.07%
9	Abbott Laboratories	ABT	2.72%
10	Pfizer Inc.	PFE	2.54%
11	Intuitive Surgical Inc.	ISRG	2.37%
12	Danaher Corporation	DHR	2.25%
13	Vertex Pharmaceuticals Incorporated	VRTX	2.04%
14	Bristol-Myers Squibb Company	BMY	1.87%
15	Medtronic Plc	MDT	1.85%
16	CVS Health Corporation	CVS	1.72%
17	McKesson Corporation	MCK	1.71%
18	Stryker Corporation	SYK	1.60%
19	Elevance Health Inc.	ELV	1.36%
20	Regeneron Pharmaceuticals Inc.	REGN	1.26%
21	Cigna Group	CI	1.18%
22	HCA Healthcare Inc	HCA	1.11%
23	Boston Scientific Corporation	BSX	0.95%
24	Cencora Inc.	COR	0.91%
25	Natera Inc.	NTRA	0.89%
26	Cardinal Health Inc.	CAH	0.88%
27	Becton Dickinson and Co		0.82%
28	Edwards Lifesciences Corporation	EW	0.81%
29	Agilent Technologies Inc.	A	0.76%
30	Humana Inc.	HUM	0.75%
31	Waters Corporation	WAT	0.70%
32	IQVIA Holdings Inc	IQV	0.68%
33	Veeva Systems Inc. Class A	VEEV	0.68%
34	IDEXX Laboratories Inc.	IDXX	0.67%
35	Illumina Inc.	ILMN	0.64%
36	Biogen Inc.	BIIB	0.55%
37	ResMed Inc.	RMD	0.54%
38	Mettler-Toledo International Inc		0.52%
39	GE Healthcare Technologies Inc.	GEHC	0.52%
40	Centene Corporation	CNC	0.51%
41	Zoetis Inc. Class A	ZTS	0.49%
42	Revolution Medicines Inc.	RVMD	0.48%
43	DexCom Inc.	DXCM	0.46%
44	Labcorp Holdings Inc.	LH	0.45%
45	West Pharmaceutical Services Inc.	WST	0.44%
46	Quest Diagnostics Incorporated	DGX	0.42%
47	Royalty Pharma Plc Class A	RPRX	0.40%
48	Insmed Incorporated	INSM	0.35%
49	Alnylam Pharmaceuticals Inc	ALNY	0.35%
50	United Therapeutics Corporation	UTHR	0.34%

Holdings lists from our database since Sep 30, 2026, 3 reporting dates.

Data note 1

Changes in Holdings

This compares the holdings list of Sep 30, 2026 with that of Nov 2, 2026: 6 names were added and 7 dropped out. Weights also shift without any buying or selling, because the prices of the holdings move differently.

Data note 2

Data and Charts: XUHL

Effective means the number of equally weighted holdings that would produce the same spread as this fund's 57 counted positions.

Data note 3

Key Facts

Data note 4

NAV History

The chart shows net asset value per share and is set to the current year by default. The NAV is up 18.9% year to date and up 27.4% over twelve months. The last recorded close on October 30, 2026, was at 100% of the 52-week range.

Net asset value per share in USD, set once per trading day. It is not an exchange price. Distributions are not added back, so for distributing funds the value drops by the amount paid out on the distribution date.

Net asset values from our database since Jan 16, 2024, 717 daily values.

Data note 5

Performance

Calculated from the fund's NAV history.

Data note 6

Fundamental Analysis: XUHL

Tax (Germany)

Equity ETF: 30% partial exemption (Teilfreistellung). Distributing → Vorabpauschale barely relevant. Details.